S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Cellectis (CLLS) Earnings Date, Estimates & Call Transcripts

$3.04
+0.06 (+2.01%)
(As of 12/1/2023 ET)
Compare
Today's Range
$2.83
▼
$3.09
50-Day Range
$0.96
▼
$3.19
52-Week Range
$0.96
▼
$4.04
Volume
150,238 shs
Average Volume
730,464 shs
Market Capitalization
$168.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.75
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Mar. 13Estimated
Actual EPS
(Nov. 6)
-$0.31 Beat By $0.05
Consensus EPS
(Nov. 6)
-$0.36
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CLLS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLLS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellectis Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.91)($0.25)($0.58)
Q2 20232($0.86)($0.41)($0.64)
Q3 20232($0.78)($0.39)($0.59)
Q4 20232($0.38)$1.22$0.42
FY 20238($2.93)$0.17($1.38)

CLLS Earnings Date and Information

Cellectis last announced its earnings results on November 6th, 2023. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.05. The business had revenue of $1.64 million for the quarter, compared to analysts' expectations of $4.03 million. Cellectis has generated ($1.67) earnings per share over the last year (($1.67) diluted earnings per share). Earnings for Cellectis are expected to grow in the coming year, from ($1.53) to ($1.06) per share. Cellectis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off prior year's report dates.

Cellectis Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/13/2024
Estimated)		------- 
11/6/2023Q3 2023($0.36)($0.31)+$0.05($0.31)$4.03 million$1.64 million
8/3/2023Q2 2023($0.38)($0.14)+$0.24($0.09)$7.80 million$2.00 million
5/4/2023Q1 2023($0.30)($0.58)($0.28)($0.58)$9.30 million$3.56 million
3/8/2023Q4 2022($0.75)($0.57)+$0.18($0.55)$20.48 million$17.32 million
11/3/2022Q3 2022($0.58)($0.63)($0.05)($0.63)$22.45 million$1.92 million
8/4/2022Q2 2022($0.73)($0.42)+$0.31($0.42)$16.50 million$2.77 million
5/12/2022Q1 2022($0.62)($0.70)($0.08)($0.70)$22.85 million$3.83 million
3/3/2022Q4 2021($1.05)($0.55)+$0.50($0.55)$12.30 million$13.66 million    
12/8/2021Q3($0.80)($0.82)($0.02)---    
11/4/2021Q3 2021($0.82)($0.82)-($0.82)$11.50 million$10.83 million    
8/5/2021Q2 2021($0.75)($0.88)($0.13)($0.88)$12.43 million$14.62 million    
5/6/2021Q1 2021($0.82)($0.28)+$0.54($0.28)$8.14 million$27.97 million  
3/4/2021Q4($1.01)($0.95)+$0.06($0.95)$6.25 million$15.63 million  












Cellectis Earnings - Frequently Asked Questions

When is Cellectis's earnings date?

Cellectis has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off last year's report dates. Learn more on CLLS's earnings history.

Did Cellectis beat their earnings estimates last quarter?

In the previous quarter, Cellectis (NASDAQ:CLLS) reported ($0.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.36) by $0.05. Learn more on analysts' earnings estimate vs. CLLS's actual earnings.

How much revenue does Cellectis generate each year?

Cellectis (NASDAQ:CLLS) has a recorded annual revenue of $16.50 million.

How much profit does Cellectis generate each year?

Cellectis (NASDAQ:CLLS) has a recorded net income of -$106.14 million. CLLS has generated -$1.67 earnings per share over the last four quarters.

What is Cellectis's EPS forecast for next year?

Cellectis's earnings are expected to grow from ($1.53) per share to ($1.06) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:CLLS) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -